Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2025Safety and Risk of PharmacotherapyOpen Access

Multi-Omics in Predicting Lamotrigine Neurotoxicity: Current Opportunities (Review)

View Full Paper
Ask AI
Bookmark
Share

Authors

NSN. А. ShnayderVGV. V. GrechkinaРНР. Ф. Насырова

Discussion

Loading...

Member takes

Overview

Review discusses how pharmacogenomics influences lamotrigine neurotoxicity in epilepsy treatment, highlighting the need for personalized therapy.

Key Points

  • Lamotrigine neurotoxicity can be influenced by genetic factors, leading to serious adverse effects and complications.
  • Toxic lamotrigine metabolites persist in circulation, affecting neurotransmission and synaptic health in patients.
  • Monitoring toxic metabolites and conducting pharmacogenomic tests may optimize lamotrigine therapy and reduce risks.
  • Assessing drug distribution is essential for understanding lamotrigine's safety and efficacy in individual patients.

Cite This Study

Shnayder et al. (2025) studied this question.

synapsesocial.com/papers/68d463e931b076d99fa6342dhttps://doi.org/10.30895/2312-7821-2025-498
View Full Paper
Ask AI
Bookmark
Share